Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients
Autor: | J. Feliu, V Heredia-Soto, Juana Saldana, B Jiménez-Munarriz, Maria-José Molina-Garrido, Carmen Guillén-Ponce, Regina Gironés |
---|---|
Rok vydání: | 2019 |
Předmět: |
Diarrhea
0301 basic medicine Cancer Research medicine.medical_specialty Neutropenia medicine.medical_treatment Antineoplastic Agents Affect (psychology) Cardiovascular System 03 medical and health sciences 0302 clinical medicine Quality of life Neoplasms medicine Humans Molecular Targeted Therapy Intensive care medicine Geriatric Assessment Fatigue Aged Chemotherapy Performance status business.industry Cancer Anemia General Medicine medicine.disease Treatment efficacy Supportive interventions 030104 developmental biology Oncology 030220 oncology & carcinogenesis Toxicity Patient Compliance business |
Zdroj: | Clinical and Translational Oncology. 22:457-467 |
ISSN: | 1699-3055 1699-048X |
DOI: | 10.1007/s12094-019-02167-y |
Popis: | The elderly form a very heterogeneous group in relation to their general health state, degree of dependence, comorbidities, performance status, physical reserve and geriatric situation, so cancer treatment in the older patient remains a therapeutic challenge. The physiological changes associated with aging increase the risk of developing a serious toxicity induced by chemotherapy treatment, as well as other undesirable consequences as hospitalizations, dependence and non-compliance with treatment, that can negatively affect survival, quality of life and treatment efficacy. The use of hematopoietic growth factors and other active supportive interventions in the elderly can help prevent and/or alleviate these toxicities. However, we have little data on the efficacy and tolerance of support treatments in the older patient. The objective of this work is to review the most frequent toxicities of oncological treatments in the elderly and their management. |
Databáze: | OpenAIRE |
Externí odkaz: |